[{"address1": "1111 Main Street", "address2": "Suite 660", "city": "Vancouver", "state": "WA", "zip": "98660", "country": "United States", "phone": "360 980 8524", "fax": "360 799 5954", "website": "https://www.cytodyn.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jacob P. Lalezari M.D.", "age": 65, "title": "Chief Executive Officer", "yearBorn": 1960, "fiscalYear": 2025, "totalPay": 441850, "exercisedValue": 0, "unexercisedValue": 274500}, {"maxAge": 1, "name": "Mr. Robert E. Hoffman B.B.A., CPA", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2025, "totalPay": 444440, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyler  Blok", "age": 38, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1987, "fiscalYear": 2025, "totalPay": 389994, "exercisedValue": 0, "unexercisedValue": 141596}, {"maxAge": 1, "name": "Dr. Bernie  Cunningham P.M.P., Ph.D.", "title": "Vice President of Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cyrus  Arman M.B.A., Ph.D.", "age": 43, "title": "Senior Vice President of Business Operations", "yearBorn": 1982, "fiscalYear": 2025, "totalPay": 278100, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Hansen Ph.D.", "title": "Head of Research & Basic Science", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Max  Lataillade D.O., M.P.H.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cristina  De Leon", "title": "Investors", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.26, "open": 0.265, "dayLow": 0.253, "dayHigh": 0.265, "regularMarketPreviousClose": 0.26, "regularMarketOpen": 0.265, "regularMarketDayLow": 0.253, "regularMarketDayHigh": 0.265, "payoutRatio": 0.0, "beta": 1.119, "forwardPE": -1.4444443, "volume": 1739551, "regularMarketVolume": 1739551, "averageVolume": 1773437, "averageVolume10days": 1337930, "averageDailyVolume10Day": 1337930, "bid": 0.259, "ask": 0.26, "bidSize": 75913, "askSize": 5500, "marketCap": 330302688, "fiftyTwoWeekLow": 0.15, "fiftyTwoWeekHigh": 0.49, "allTimeHigh": 10.01, "allTimeLow": 0.06, "fiftyDayAverage": 0.29, "twoHundredDayAverage": 0.29225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 350366496, "profitMargins": 0.0, "floatShares": 1270229849, "sharesOutstanding": 1270395000, "heldPercentInsiders": 0.00013, "heldPercentInstitutions": 0.00034000003, "impliedSharesOutstanding": 1270395000, "bookValue": -0.095, "lastFiscalYearEnd": 1748649600, "nextFiscalYearEnd": 1780185600, "mostRecentQuarter": 1764460800, "netIncomeToCommon": -40345000, "trailingEps": -0.03, "forwardEps": -0.18, "enterpriseToEbitda": -18.347, "52WeekChange": 0.5294118, "SandP52WeekChange": 0.14799047, "quoteType": "EQUITY", "currentPrice": 0.26, "recommendationKey": "none", "totalCash": 4982000, "totalCashPerShare": 0.004, "ebitda": -19097000, "totalDebt": 27269000, "quickRatio": 0.059, "currentRatio": 0.104, "returnOnAssets": -0.70666003, "freeCashflow": 2635500, "operatingCashflow": -17419000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CYDY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "fiftyDayAverageChange": -0.030000001, "fiftyDayAverageChangePercent": -0.10344829, "twoHundredDayAverageChange": -0.032250017, "twoHundredDayAverageChangePercent": -0.11035078, "priceToBook": -2.7368422, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1166020200000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.253 - 0.265", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 1773437, "fiftyTwoWeekLowChange": 0.109999985, "fiftyTwoWeekLowChangePercent": 0.73333323, "fiftyTwoWeekRange": "0.15 - 0.49", "fiftyTwoWeekHighChange": -0.23000002, "fiftyTwoWeekHighChangePercent": -0.4693878, "fiftyTwoWeekChangePercent": 52.941177, "earningsTimestamp": 1767965400, "earningsTimestampStart": 1767965400, "earningsTimestampEnd": 1767965400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.03, "epsForward": -0.18, "corporateActions": [], "regularMarketTime": 1768597200, "exchange": "OQB", "messageBoardId": "finmb_10039157", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.26, "marketState": "CLOSED", "shortName": "CytoDyn Inc.", "longName": "CytoDyn Inc.", "displayName": "CytoDyn", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]